GMED
Globus Medical, Inc.
NYSE · Healthcare · Medical - Devices · US
$74.08
−0.11%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $1.20
- Revenue estimate
- $792.2M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $1.34
- EPS estimate
- $1.10
- Revenue actual
- $789.6M
- Revenue estimate
- $782.9M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +23.0%
- Revenue beats (12Q)
- 8
Analyst ratings
Sell-side consensus
- Consensus
- Strong Buy
- Price target
- $95
- PT range
- $80 – $115
- Analysts
- 7
5 Buy2 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $1.10 | $1.34 | Beat 21.82% | $789.6M |
| May 7, 2026 | $0.92 | $1.12 | Beat 21.74% | $759.9M |
| Feb 24, 2026 | $1.06 | $1.03 | Miss -2.83% | $826.4M |
| Nov 6, 2025 | $0.78 | $1.18 | Beat 51.09% | $769.0M |
| Aug 7, 2025 | $0.76 | $0.86 | Beat 13.16% | $745.3M |
| May 8, 2025 | $0.74 | $0.68 | Miss -8.60% | $598.1M |
| Feb 20, 2025 | $0.74 | $0.84 | Beat 13.51% | $657.3M |
| Feb 20, 2024 | $0.59 | $0.60 | Beat 1.69% | $616.5M |
| Aug 3, 2023 | $0.59 | $0.63 | Beat 6.78% | $291.6M |
| May 4, 2023 | $0.51 | $0.53 | Beat 3.92% | $276.7M |
| Feb 21, 2023 | $0.56 | $0.59 | Beat 5.36% | $274.5M |
| Aug 4, 2022 | $0.53 | $0.56 | Beat 5.66% | $263.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026